Number of apoptotic cells as a prognostic marker in invasive breast cancer

被引：0

作者：

De Jong J.S. ^{[1
]}

Van Diest P.J. ^{[1
]}

Baak J.P.A. ^{[1
]}

机构：

[1] Department of Pathology, Free University Hospital Amsterdam, NL-1007 MB Amsterdam

来源：

British Journal of Cancer | 2000年 / 82卷 / 2期

关键词：

Apoptosis; Breast cancer; Prognostic factor; Proliferation;

D O I：

10.1054/bjoc.1999.0928

中图分类号：

学科分类号：

摘要：

Apoptosis plays an important role in tumorigenesis. Tumour growth is determined by the rate of cell proliferation and cell death. We counted the number of apoptotic cells in haematoxylin and eosin (HandE)-stained tumour sections in series of 172 grade I and II invasive breast cancers with long-term follow-up. The number of apoptotic cells in ten high-power fields were converted to the number of apoptotic cells per mm2 to obtain the apoptotic index (AI). The AI showed a positive correlation to the mitotic activity index (MAI) (P = 0.0001), histological grade (P < 0.0001) and worse tumour differentiation. Patients with high AI showed shorter overall survival than patients with low AI in the total group as well as in the lymph node-positive group. Tumour size, MAI, lymph node status and AI were independent prognostic indicators in multivariate analysis. The AI was shown to be of additional prognostic value to the MAI in the total patients group as well as in the lymph node-positive group. The correlation between the AI and the MAI points to linked mechanisms of apoptosis and proliferation. Since apoptotic cells can be counted with good reproducibility in HandE-stained tumour sections, the AI may be used as an additional prognostic indicator in invasive breast cancer.

引用

页码：368 / 373

页数：5

共 44 条

[1]

Allan D.J., Howell A., Roberts S.A., Williams G.T., Watson R.J., Coyde J.D., Clarke R.B., Laidlaw I.J., Potten C.S., Reduction in apoptosis relative to mitosis in histologically normal epithelium accompanies fibrocyctic change and carcinoma of the premenopausal human breast, J Pathol, 163, pp. 337-342, (1991)

[2]

Baak J.P.A., Van Dop H., Kurver P.H.J., Hermans J., The value of morphometry to classic prognosticators in breast cancer, Cancer, 56, pp. 374-382, (1985)

[3]

Barbareschi M., Caffo O., Veronese S., Leek R.D., Fina P., Fox S., Bonzanini M., Girlando S., Morelli L., Eccher C., Pezzella F., Doglioni C., Dalla Palma P., Harris A., Bcl-2 and p53 expression in node-negative breast carcinoma: A study with long-term follow-up, Hum Pathol, 27, pp. 1149-1155, (1996)

[4]

Bargou R.C., Dainel P.T., Mapara M.Y., Bommert K., Wagener C., Killinich B., Royer H.D., Dorken B., Expression of the bcl-2 gene family in normal and malignant breast tissue: Low bax-alpha expression in tumor cells correlates with resistance towards apoptosis, Int J Cancer, 60, pp. 854-859, (1995)

[5]

Berardo M.D., Elledge R.M., De Moor C., Clark G.M., Osborne C.K., Allred D.C., Bcl-2 and apoptosis in lymph node positive carcinoma, Cancer, 82, pp. 1296-1302, (1998)

[6]

Berns E.M.J.J., Klijn J.G.M., Van Putten W.L.J., Van Staveren I.L., Portengen H., Foekens J.A., c-myc amplification is a better prognostic factor than HER2/neu amplification in primary breast cancer, Cancer Res, 52, pp. 1107-1113, (1992)

[7]

Borg A., Baldetorp B., Ferno M., Olsson H., Sigurdsson H., c-myc amplification is an independent prognostic factor in postmenopausal breast cancer, Int J Cancer, 51, pp. 687-691, (1992)

[8]

Clayton F., Pathologic correlates of survival in 378 lymph node-negative infiltrating ductal breast carcinomas. Mitotic count is the best single predictor, Cancer, 68, pp. 1309-1317, (1991)

[9]

Davis P.L., Shaiu W.L., Scott G.L., Iglehart J.D., Hsieh T.S., Marks J.R., Complex response of breast epithelial cell lines to topoisomerase inhibitors, Anticancer Res, 18, pp. 2918-2932, (1998)

[10]

Van Diest P.J., Baak J.P.A., The morphometric multivariate prognostic index (MPI) is the strongest prognosticator in premenopausal lymph node negative and lymph node positive breast cancer patients, Hum Pathol, 22, pp. 479-489, (1992)

← 1 2 3 4 5 →